Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/9/2026
-
The Cerbat Gem
5/9/2026
-
MarketBeat
5/8/2026
-
TipRanks Financial Blog
5/7/2026
-
Seeking Alpha - Healthcare
5/7/2026
-
Globe Newswire
4/29/2026
-
MarketBeat
4/21/2026
-
Holdings Channel
4/21/2026
-
MarketBeat
4/21/2026
-
MarketBeat
4/20/2026
-
MarketBeat
4/20/2026
-
MarketBeat
4/13/2026
-
MarketBeat
4/7/2026
-
Globe Newswire
3/31/2026
-
Globe Newswire
3/30/2026
-
MarketBeat
3/28/2026
-
Simply Wall St
3/28/2026
-
Simply Wall St
3/28/2026
-
Ticker Report
3/27/2026
-
MarketBeat
3/27/2026
-
MarketBeat
3/26/2026
-
SeekingAlpha
3/26/2026
-
Seeking Alpha: Transcripts
3/26/2026
-
MarketBeat
3/26/2026
-
MarketBeat
3/26/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
412 481 2210
Address
2500 Westchester Ave.
Purchase, NY 10577
Purchase, NY 10577
Country
Year Founded
Business Description
Sector
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and...
more